Miller Value Partners’s Precigen PGEN Stock Holding History

Miller Value Partners’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,110,000	Closed	-$6.08M	–	84
2019 Q4	$6.08M	Hold	1,110,000	–	–	0.22%	53
2019 Q3	$6.35M	Hold	1,110,000	–	–	0.26%	52
2019 Q2	$8.5M	Hold	1,110,000	–	–	0.32%	46
2019 Q1	$5.84M	Hold	1,110,000	–	–	0.23%	53
2018 Q4	$7.26M	Hold	1,110,000	–	–	0.33%	46
2018 Q3	$19.1M	Hold	1,110,000	–	–	0.62%	37
2018 Q2	$15.5M	Buy	1,110,000 +110,000	+11%	+$1.86M	0.58%	36
2018 Q1	$15.3M	Hold	1,000,000	–	–	0.64%	39
2017 Q4	$3.9M	Buy	+1,000,000	New	+$14.9M	0.17%	57

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Miller Value Partners's PGEN Position: Q2 2023 in Review

Miller Value Partners sold out of Precigen (PGEN) in Q2 2023, closing a stake of 9,503,782 shares — an estimated $10.1M sold.

Miller Value Partners first reported a position in PGEN in Q4 2013 and held it in 36 quarters. The position peaked at $144M in Q2 2015. 138 funds tracked by Wall St. Rank hold PGEN as of Q2 2023.

Miller Value Partners reported no remaining Precigen position as of Q2 2023 after selling out during the quarter.
Miller Value Partners sold 9,503,782 Precigen shares in Q2 2023, an estimated $10.1M.
Miller Value Partners first reported a position in Precigen in Q4 2013 and held it in 36 quarters.
Miller Value Partners's Precigen position peaked at $144M in Q2 2015.
138 funds tracked by Wall St. Rank held Precigen as of Q2 2023.

Based on Miller Value Partners's 13F filing for Q2 2023, filed 14 Aug 2023.